Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биохэвен Фармасьютикэл Холдинг Компани Лтд.filedCriticalБиохэвен Фармасьютикэл Холдинг Компани Лтд.
Priority claimed from PCT/US2019/023940external-prioritypatent/WO2019191008A1/en
Publication of EA202092278A1publicationCriticalpatent/EA202092278A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Раскрыты способы лечения связанных с CGRP расстройств, например мигрени, посредством введения пациенту, нуждающемуся в этом, римегепанта или его фармацевтически приемлемой соли. Также раскрыты фармацевтические композиции, содержащие римегепант, и наборы, включающие в себя фармацевтические композиции и инструкции.Methods are disclosed for treating CGRP-related disorders such as migraine by administering to a patient in need thereof a remegepant or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions containing remegepant and kits including pharmaceutical compositions and instructions.
EA202092278A2018-12-102019-03-25
RIMEGEPANT FOR CGRP-RELATED DISORDERS
EA202092278A1
(en)